Company Filing History:
Years Active: 2006
Title: Innovations in Vaccine Development by José Manuel Gonzalez Martinez
Introduction
José Manuel Gonzalez Martinez is a notable inventor based in Murcia, Spain. He has made significant contributions to the field of vaccine development, particularly through his innovative patent that focuses on recombinant defective viral genomes. His work aims to enhance the efficacy of vaccines against various infectious agents.
Latest Patents
José Manuel Gonzalez Martinez holds a patent titled "Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines." This patent describes vectors that comprise a recombinant defective viral genome expressing at least one antigen suitable for inducing systemic and secretory immune responses. The vectors are designed to be used in the formulation of mono- and polyvalent vaccines, particularly targeting infectious agents affecting animals such as pigs, dogs, and cats. The defective viral genome relies on a helper virus for replication and encapsidation, making it a crucial component in vaccine manufacturing.
Career Highlights
Throughout his career, José Manuel Gonzalez Martinez has been associated with Cyanamid Iberica, S.A., where he has contributed to various research initiatives. His expertise in virology and immunology has positioned him as a key figure in the development of advanced vaccine technologies.
Collaborations
José Manuel has collaborated with esteemed colleagues such as Luis Enjuanes Sanchez and Juan Plana Duran. These collaborations have further enriched his research and have led to advancements in the field of vaccine development.
Conclusion
José Manuel Gonzalez Martinez's innovative work in the realm of recombinant viral genomes has the potential to revolutionize vaccine formulation. His contributions are vital for enhancing the protection against infectious diseases in animals, showcasing the importance of innovation in public health.